Jeffrey A. Cooper is a Professor of Law at Quinnipiac University School of Law , where he teaches courses in estate planning, wills and trusts, and taxation. He previously served as Associate Dean for Research and Faculty Development and is currently faculty adviser to the Quinnipiac Probate Law Journal . Education: AB from Harvard University, JD from Yale University, LLM from New York University Research Interests: His work focuses on tax policy , estate and gift taxation , and the intersection of federal tax law with state probate systems . He specializes in trust enforceability , uniform trust code , and historical analysis of tax legislation. Publications: Recent articles address perpetual trusts , state death tax decline , and curriculum reforms in estate planning education. His scholarship is widely published in national law journals and cited in casebooks. Scientific Awards: Academic Fellow, American College of Trust and Estate Counsel (ACTEC) Faculty Scholar, Quinnipiac University Professional Background: Before academia, Cooper practiced law for over a decade as a principal at Cummings & Lockwood, senior officer at United States Trust Company, and special counsel to Shipman & Goodwin. He also served as a senior adviser to Fiduciary Trust Company International.
Dr. Carolyn Emery is a Professor in the Faculty of Kinesiology at the University of Calgary, with joint appointments in Pediatrics and Community Health Sciences at the Cumming School of Medicine. She holds leadership roles as Chair of the Sport Injury Prevention Research Centre (an International Olympic Committee Research Centre) and the Alberta Children’s Hospital Research Institute. Her affiliations include the McCaig Institute for Bone and Joint Health, Hotchkiss Brain Institute, and O’Brien Institute for Public Health. Dr. Emery’s education includes a BScPT from Queen’s University (1988), MSc in Epidemiology from the University of Calgary (1999), and PhD in Epidemiology from the University of Alberta (2004). Her research focuses on injury prevention in youth sports, concussion, and pediatric rehabilitation, aiming to reduce long-term health consequences such as osteoarthritis and post-concussion syndrome. She leads major grants including CIHR’s “SHRed Injuries” and NFL-funded concussion surveillance programs. Her research interests emphasize practical interventions for injury prevention, including neuromuscular training and policy changes. Recent work explores concussion outcomes in adolescents, biomechanical injury mechanisms, and global sport safety initiatives. She has published extensively on topics like sport-related musculoskeletal injuries, concussion management, and the epidemiology of youth sports. Dr. Emery has received over 20 awards, including the Royal Society of Canada Fellowship, Killam Professorship, and CIHR Canada Research Chair. Her work bridges clinical practice, policy, and community engagement to enhance public health outcomes in sports and youth recreation. Her lab, the Sport Injury Prevention Research Centre, collaborates internationally to develop evidence-based strategies for injury prevention. Current projects include evaluating the impact of tackle laws in rugby, head acceleration in wrestling, and long-term consequences of pediatric concussions.
Bobak Mortazavi is an Associate Professor in the Department of Computer Science & Engineering at Texas A&M University. His research focuses on medical analytics, machine learning, wearable sensors, and cyber-physical systems. He leads interdisciplinary projects in healthcare technology, including AI-driven diagnostics and predictive modeling for cardiovascular diseases. He has received notable awards such as the Best Demonstration Award at IEEE EMBS 2012 and the Best Paper Award at the Fourth International Conference on Data Analytics 2015. His work bridges machine learning with clinical applications, emphasizing practical solutions for healthcare challenges. Recent research includes developing AI tools for aortic stenosis detection, electrolyte estimation via ECG, and real-time patient monitoring systems. He collaborates with industry and academic partners to advance telemedicine and wearable health technologies. Key contributions include the SMART-LV project for smartphone-based cardiac diagnostics and the ArterialNet framework for blood pressure reconstruction using wearable sensors. His work is published in top journals like IEEE Journal of Biomedical and Health Informatics and Elsevier's Pervasive and Mobile Computing.
Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.
Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.
Roger Giner-Sorolla is Professor of Social Psychology at the University of Kent's School of Psychology, where he has been a faculty member since 2001 after completing his PhD at New York University in 1996. He served as Editor-in-Chief of the Journal of Experimental Social Psychology from 2016-2022 and currently leads a Leverhulme Foundation grant examining moral heroism across professions. His academic journey includes a postdoctoral fellowship at the University of Virginia and has established him as a leading figure in social and moral psychology. Professor Giner-Sorolla's research focuses on the social role of emotions, particularly moral emotions including self-condemning emotions (guilt and shame) and other-condemning emotions (anger, contempt, and disgust). His work extends to intergroup apologies, dehumanization, emotionally driven prejudice, and collective moral roles, with a notable side interest in the ironic enjoyment of music and aesthetic experiences. He is a strong advocate for transparency in scientific reporting, having written extensively on improved reporting guidelines, pre-registration, and open science practices. Analysis of his recent publications reveals a consistent focus on moral psychology with expanding interdisciplinary reach. His work bridges traditional social psychology with emerging areas including cross-cultural emotion research, replication science, and historical memory. The trend shows increasing attention to methodological rigor while maintaining core interests in emotion and morality, with growing emphasis on practical applications in conflict resolution and intergroup relations. Fellow of the Association for Psychological Science Member of Rising Stars selection committee (2023-2024) Promising Scholars Award (University of Kent, 2006) Vacation Research Scholarship (Wellcome Trust, 2005) Multiple ESRC grants totaling over £400,000 European Science Foundation Workshop Award (2004) Professor Giner-Sorolla has supervised an impressive number of PhD students, with 17 doctoral candidates listed in the documentation including both current and past students. His grant portfolio demonstrates significant research impact with funding from major organizations including ESRC, Wellcome Trust, and Leverhulme Foundation. His supervision style appears to encourage students to pursue research that aligns with his core interests in moral emotions while allowing exploration of novel applications and contexts. While the documentation doesn't specify laboratory or research team structures, his extensive collaborative work suggests leadership of research groups focused on moral psychology and emotion research. His numerous international collaborations and invited workshops indicate an active research program with global reach, likely involving multiple research teams working on interconnected projects related to his core interests in moral psychology and scientific methodology.
Susan Fino is a Professor at the College of Liberal Arts and Sciences, Wayne State University. Her research focuses on public law, American constitutional law, administrative law, and the role of state supreme courts. She holds a B.A. from Johns Hopkins University, an M.A. and Ph.D. from Rutgers University. She has received the President's Award for Excellence in Teaching. Her courses include American Government (PS1010) and Constitutional Law (PS5110/PS5120), taught across multiple terms from 2023 to 2025. Dr. Fino's research explores judicial federalism, state constitutional frameworks, and legal interpretations of rights. Her work analyzes topics like church-state relations, taxation provisions in state constitutions, and assisted suicide debates. She has written extensively on state supreme court dynamics, including landmark cases and institutional performance metrics. Her scholarship bridges legal theory with practical governance challenges at both state and federal levels. Her publications span over three decades, addressing evolving legal landscapes such as the Rehnquist Court’s federalism approach and technological impacts on criminal sentencing. She consistently engages with issues at the intersection of law, politics, and societal values.
Bo Li is an Associate Professor at the University of Illinois at Urbana-Champaign, affiliated with the Siebel School of Computing and Data Science. Her research focuses on trustworthy machine learning, emphasizing robustness, privacy, and security in AI systems. She leads the Secure Learning Lab (SL²), exploring adversarial attacks and defenses across digital and physical domains. Key contributions include foundational work on adversarial examples, robust learning frameworks, and privacy-preserving techniques. Her academic roles include advisory board positions at the Center for Artificial Intelligence Innovation (CAII) and membership in the Information Trust Institute (ITI). She collaborates with institutions like the Advanced Digital Science Center (ADSC) and the Quantum Information Science and Technology Center (IQUIST). Notable recognitions include the IJCAI Computers and Thought Award (2022), MIT Technology Review's 35 Innovators Under 35 (2020), and multiple best paper awards. Recent work addresses AI safety through frameworks like ShieldAgent and AutoRedTeamer, aiming to enhance system resilience against adversarial threats. Her research spans theoretical guarantees, practical defenses, and ethical AI deployment. Students advised include Chulin Xie, Linyi Li, and Boxin Wang, who have received prestigious fellowships such as the IBM PhD Fellowship and Rising Stars in ML Awards. Advising: Guides PhD students in adversarial ML, privacy, and security. Labs/Teams: Secure Learning Lab (SL²), collaboration with ALERT program. Grants/Funding: NSF CAREER Award, Amazon/Google Faculty Awards, and industry partnerships.
Brendan Russo serves as an Associate Professor in the Department of Civil Engineering, Construction Management, and Environmental Engineering at Northern Arizona University, where he conducts influential research in transportation safety and traffic engineering. His work focuses on improving safety outcomes for vulnerable road users through rigorous analysis of crash data, traffic operations, and emerging mobility technologies, with significant contributions to Arizona-specific transportation challenges and national safety practices. Russo's research program centers on bicycle and pedestrian safety, crash severity analysis, and the integration of autonomous systems into transportation networks. He employs advanced methodologies including spatial analysis, statistical modeling (e.g., random parameters bivariate probit models), and observational studies to investigate traffic stress levels, intersection safety, and the impacts of infrastructure treatments. His work consistently bridges theoretical transportation engineering with practical applications for safer community design. Analysis of Russo's recent publications reveals a strong emphasis on emerging transportation technologies and their safety implications, particularly regarding autonomous delivery robots and vehicle-pedestrian interactions, while maintaining core focus on traditional safety concerns like bicycle crash frequency and severity. His research demonstrates increasing integration of spatiotemporal analysis and scenario-based testing methodologies, with a clear geographic concentration on Arizona metropolitan regions that provides valuable localized insights applicable to broader transportation contexts. No scientific awards were mentioned in the provided text. No specific information about advising responsibilities or grant funding was provided in the text, though his extensive publication record and dataset contributions indicate active research leadership. Russo collaborates within a robust research network centered on transportation safety, frequently partnering with colleagues including Gehrke, Smaglik, and Holliday on projects involving field data collection, bicycle infrastructure evaluation, and safety performance metrics. His work leverages both observational studies and simulation approaches to develop data-driven guidance for transportation practitioners, with particular attention to Arizona's unique transportation environment and metropolitan planning challenges.
Jieyu Zhao is an Assistant Professor in the Thomas Lord Department of Computer Science at the University of Southern California (USC), part of the Viterbi School of Engineering. She holds a Ph.D. from UCLA and was a NSF Computing Innovation Fellow at the University of Maryland. Her research focuses on fairness in machine learning and NLP, particularly addressing biases in AI systems and promoting ethical AI practices. Education: Ph.D. in Computer Science (UCLA, 2021), Postdoc at University of Maryland (2022-2023), and multiple research internships at Microsoft Research, Google Research, and AI2. She also completed her undergraduate studies at the University of Virginia. Research interests include bias detection and mitigation in NLP models, trustworthy AI, and social responsibility in technology. Her work has been recognized with awards such as the EMNLP Best Long Paper Award (2017), Microsoft PhD Fellowship (2020), and EECS Rising Star (2021). She has delivered talks at conferences like NeurIPS, EMNLP, and USC Law School, and serves on committees including AAAI workflow chair. Her lab explores topics like alignment of LLMs, fairness in sequential decision-making, and ethical model interventions. She actively participates in initiatives promoting diversity and inclusion in AI, such as the UN-WOMEN Beijing panel on gender equality. Awards: 100 Brilliant Women in AI Ethics (2025), Capital One Research Award (2024), Microsoft PhD Fellowship (2020) Grants: NSF Computing Innovation Fellowship, USC Viterbi funding Labs/Teams: Leads the USC Lab focused on trustworthy AI and ethical NLP
Elena Agapie is an Assistant Professor in the Department of Informatics at the Donald Bren School of Information & Computer Sciences, University of California, Irvine. Her research lies at the intersection of human-computer interaction (HCI), health, and behavior change, focusing on designing technologies that support individuals in adopting and maintaining healthy behaviors through human-centered approaches. She is affiliated with the Connected Learning Lab and the Institute for Future Health at UCI. Her educational background includes a PhD in Human Centered Design and Engineering from the University of Washington, an MS in Computer Science from Harvard University, and a BS in Computer Science from Jacobs University Bremen in Germany. She has also conducted research at Microsoft Research, FXPAL, Intel Labs, and NASA Jet Propulsion Lab. Elena's research focuses on designing tools that integrate evidence-based behavioral interventions with user needs, particularly in mental health, chronic disease management, and social support systems. She explores how technology can support therapist-client collaboration, enable tailored health interventions, and leverage crowd expertise for personalized behavior change plans. Her work often involves participatory design, qualitative studies, and prototyping of interactive systems for diverse populations, including youth, hospitalized patients, and underserved communities. Her recent publications, primarily in top-tier venues like CHI and CSCW, reflect a strong trend toward social computing in health, longitudinal behavior support, and the design of inclusive digital health tools. Key themes include goal setting, conversational agents, social sharing in health tracking, and cross-disciplinary collaboration in health technology development. Best Paper Award (top 1%) at CHI 2017 Honorable Mention Best Paper Award (top 5%) at CHI 2016 Best Paper Award (top 1%) at HCOMP 2015 Honorable Mention Best Paper Award (top 5%) at CHI 2013 Elena has been funded by the National Science Foundation, National Institutes of Health, and UCI internal grants. She actively mentors PhD students including Bruna Oewel, Meeshu Agnihotri, and Mehreen Masood, and is currently recruiting students interested in HCI, health, and behavior change. She previously led the outreach program in the HCDE department at the University of Washington, creating workshops that introduced K–12 students to engineering and human-centered design, reaching over 2,000 students across public schools and community events. She runs initiatives to broaden participation in computing and advises undergraduate students in outreach and curriculum development. Her lab collaborates with clinical partners and interdisciplinary teams to ensure real-world impact of her research.
Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.
Christopher Weidlich is an Assistant Professor of Clinical in the School of Nursing and Health Studies at the University of Miami. His academic focus includes psychiatric nursing, mental health education, and healthcare provider well-being. He is involved in research addressing simulation-based education, mental health disorders in occupational groups such as fire investigators, and interventions to improve resilience among healthcare providers. His research interests span simulation modalities in psychiatric nursing education, organizational stigma's impact on mental health service utilization, and substance abuse trends like xylazine adulteration. He has also contributed to studies on military healthcare, including resilience programs for providers and PEMF therapy for chronic pain. Dr. Weidlich’s work is supported by his affiliation with the University of Miami’s School of Nursing and Health Studies, leveraging resources such as the Simulation Hospital Advancing Research and Education (S.H.A.R.E.®) facility. His research emphasizes practical applications in clinical settings and improving patient outcomes through innovative educational and therapeutic approaches.
Mark R. Pittelkow is a Professor of Dermatology at the Mayo Clinic, holding a primary appointment as a Consultant in the Department of Dermatology. He completed his MD at Mayo Medical School and advanced training through Mayo Graduate School of Medicine and Northwestern University. His research focuses on cutaneous lymphomas, photoprotection, and skin cancer, with leadership roles in international guidelines (ISCL/EORTC). He contributes to clinical trials, medical education, and interdisciplinary research through affiliations like the Mayo Clinic Comprehensive Cancer Center and Regenerative Biotherapeutics. Education: MD (Mayo Medical School), MS (Biological Sciences, Northwestern), BA (Northwestern University). Research spans cutaneous lymphoma classification, immunology, and translational dermatology. Notable publications address staging systems for mycosis fungoides/Sezary syndrome and photoprotection strategies. His work integrates clinical practice with molecular mechanisms, such as JAK inhibitor responses in lichen planus. Labs/Teams: Collaborates with Mayo Clinic Cancer Center and interdisciplinary groups in immunotherapy and regenerative medicine. Supervises clinical trials and postdoctoral training programs.
Alison Ledgerwood is a Professor in the Department of Psychology at the University of California, Davis, and Principal Investigator of the Attitudes and Group Identity Lab. Her research examines how social context shapes attitudes and preferences, with a focus on open and inclusive scientific practices. Ph.D., Social Psychology, New York University (2008) M.A., Psychology, New York University (2006) B.A., Psychology, Amherst College (2003) Her research explores psychological distance , framing effects , and system justification theory , while methodologically advancing preregistration , collaborative science , and equity in publishing . She also investigates group identity dynamics and implicit/explicit bias measurement . Recent publications highlight her work on racial bias methodology , open science reform , and contextual framing . Awards include the 2024 Distinguished Service to the Society award, 2021 UC Davis Advising and Mentoring Award, and 2017 SPSP Service to the Field award. 2024 Distinguished Service to the Society, SPSP 2021 UC Davis Graduate Advising and Mentoring Award 2017 Service to the Field, SPSP Hellman Fellowship (2010-2011), UC Davis UC Davis Chancellor's Fellow APS Fellow SESP Fellow Ledgerwood advises on scientific integrity through roles like Chair of the Transparency and Openness Promotion (TOP) II Guidelines Task Force and Anti Colorism and Eurocentrism in Methods and Practices (ACEMAP) Task Force. Her lab fosters contextual evaluation studies and psychological distance frameworks .
